|
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid |
|
CHEBI:137354 |
|
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid |
|
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14S- and 21R-positions. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
CHEBI:140213
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H32O4/c1-20(23)16-12-10-11-14-18-21(24)17-13-8-6-4-2-3-5-7-9-15-19-22(25)26/h2-3,6-9,11-14,16-17,20-21,23-24H,4-5,10,15,18-19H2,1H3,(H,25,26)/b3-2-,8-6-,9-7-,14-11-,16-12-,17-13+/t20-,21-/m1/s1 |
FRJZMMUVPROLHN-KZPAZRNKSA-N |
C(C(O)=O)C/C=C\C/C=C\C\C=C/C=C/[C@H](C/C=C\C/C=C\[C@@H](C)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
apoptosis inhibitor
Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
has role
angiogenesis inhibitor
(CHEBI:48422)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
has role
apoptosis inhibitor
(CHEBI:68494)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
has role
mouse metabolite
(CHEBI:75771)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
is a
dihydroxydocosahexaenoic acid
(CHEBI:137348)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
is conjugate acid of
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoate
(CHEBI:136533)
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
is enantiomer of
(4Z,7Z,10Z,12E,14R,16Z,19Z,21S)-dihydroxydocosahexaenoic acid
(CHEBI:137368)
|
|
Incoming
|
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoate
(CHEBI:136533)
is conjugate base of
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
(4Z,7Z,10Z,12E,14R,16Z,19Z,21S)-dihydroxydocosahexaenoic acid
(CHEBI:137368)
is enantiomer of
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid
(CHEBI:137354)
|
(4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-14,21-dihydroxydocosa-4,7,10,12,16,19-hexaenoic acid
|
(14S,21R)-DiHDoHE
|
ChEBI
|
(14S,21R)-dihydroxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid
|
ChEBI
|
14(S),21(R)-diHDHA
|
SUBMITTER
|
14(S),21(R)-dihydroxydocosahexaenoic acid
|
ChEBI
|
14S,21R-diHDHA
|
ChEBI
|
19965612
|
PubMed citation
|
Europe PMC
|
21112969
|
PubMed citation
|
Europe PMC
|
21839062
|
PubMed citation
|
Europe PMC
|
21846180
|
PubMed citation
|
Europe PMC
|
23386851
|
PubMed citation
|
Europe PMC
|
|